212 related articles for article (PubMed ID: 24721836)
1. PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?
McDonald AJ; Millhauser GL
Prion; 2014; 8(2):183-91. PubMed ID: 24721836
[TBL] [Abstract][Full Text] [Related]
2. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
3. α-Cleavage of cellular prion protein.
Liang J; Kong Q
Prion; 2012; 6(5):453-60. PubMed ID: 23052041
[TBL] [Abstract][Full Text] [Related]
4. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
Liang J; Wang W; Sorensen D; Medina S; Ilchenko S; Kiselar J; Surewicz WK; Booth SA; Kong Q
J Biol Chem; 2012 May; 287(20):16510-20. PubMed ID: 22447932
[TBL] [Abstract][Full Text] [Related]
5. Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.
Lewis V; Johanssen VA; Crouch PJ; Klug GM; Hooper NM; Collins SJ
Cell Mol Life Sci; 2016 Feb; 73(3):667-83. PubMed ID: 26298290
[TBL] [Abstract][Full Text] [Related]
6. PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site.
Haigh CL; Lewis VA; Vella LJ; Masters CL; Hill AF; Lawson VA; Collins SJ
Cell Res; 2009 Sep; 19(9):1062-78. PubMed ID: 19597535
[TBL] [Abstract][Full Text] [Related]
7. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
8. Application of N-Terminal Labeling Methods Provide Novel Insights into Endoproteolysis of the Prion Protein
Gomez-Cardona E; Eskandari-Sedighi G; Fahlman R; Westaway D; Julien O
ACS Chem Neurosci; 2024 Jan; 15(1):134-146. PubMed ID: 38095594
[TBL] [Abstract][Full Text] [Related]
9. Shedding light on prion disease.
Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
Prion; 2015; 9(4):244-56. PubMed ID: 26186508
[TBL] [Abstract][Full Text] [Related]
10. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
Sunyach C; Checler F
J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
[TBL] [Abstract][Full Text] [Related]
11. Endoproteolytic processing of the mammalian prion glycoprotein family.
Mays CE; Coomaraswamy J; Watts JC; Yang J; Ko KW; Strome B; Mercer RC; Wohlgemuth SL; Schmitt-Ulms G; Westaway D
FEBS J; 2014 Feb; 281(3):862-76. PubMed ID: 24286250
[TBL] [Abstract][Full Text] [Related]
12. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
[TBL] [Abstract][Full Text] [Related]
13. Cellular prion protein: from physiology to pathology.
Yusa S; Oliveira-Martins JB; Sugita-Konishi Y; Kikuchi Y
Viruses; 2012 Nov; 4(11):3109-31. PubMed ID: 23202518
[TBL] [Abstract][Full Text] [Related]
14. The role of the prion protein in the internalization of α-synuclein amyloids.
De Cecco E; Legname G
Prion; 2018 Jan; 12(1):23-27. PubMed ID: 29308725
[TBL] [Abstract][Full Text] [Related]
15. Neuronal zinc regulation and the prion protein.
Watt NT; Griffiths HH; Hooper NM
Prion; 2013; 7(3):203-8. PubMed ID: 23764834
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
Daniels M; Cereghetti GM; Brown DR
Eur J Biochem; 2001 Dec; 268(23):6155-64. PubMed ID: 11733010
[TBL] [Abstract][Full Text] [Related]
17. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Béland M; Roucou X
Prion; 2014; 8(1):106-10. PubMed ID: 24335160
[TBL] [Abstract][Full Text] [Related]
18. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
19. PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1.
Béland M; Motard J; Barbarin A; Roucou X
J Neurosci; 2012 Sep; 32(38):13255-63. PubMed ID: 22993441
[TBL] [Abstract][Full Text] [Related]
20. Separate mechanisms act concurrently to shed and release the prion protein from the cell.
Wik L; Klingeborn M; Willander H; Linne T
Prion; 2012; 6(5):498-509. PubMed ID: 23093798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
